Unveiling biomarkers of telitacicept’s efficacy in SLE treatment through proteomics and metabolomics

20260 citationsJournal Articlegold Open Access

Authors

Huiyu Nie · Central South University

Siyuan Chang · Central South University

Hanhan Chen · Central South University

Jiahui Shi · Central South University

Shu Li · Central South University

Xiaofei Peng · Central South University

Wei Cheng ·

Abstract

The above results reveal biomarkers related to the differential efficacy of Telitacicept in treating SLE patients and potential mechanisms underlying these differences, which may provide a reference for personalized treatment and mechanistic research in SLE.

Topics & Keywords

Systemic Lupus Erythematosus Research Metabolomics and Mass Spectrometry Studies Diabetes and associated disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Immunology

Volume 17, pp. 1779880-1779880

DOI: 10.3389/fimmu.2026.1779880

Field-Weighted Citation Impact: 0.00